Trial intelligence / Profile preview

Bromocriptine in Primary Aldosteronism

NCT00451672Phase 4Unknown

Sponsor
National Taiwan University Hospital
Start
Jan 2007
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of bromocriptine in primary aldosteronism (PA), sponsored by National Taiwan University Hospital. Status: unknown.

02

Drugs

bromocriptine
03

Conditions

primary aldosteronism (PA)

Beyond the preview

Go deeper on NCT00451672.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00451672.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call